The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritis
Abstract
Objective. To explore the role of proinflammatory cytokines in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), two clinically related syndromes characterized by an intense acute‐phase reaction. In particular, to determine plasma concentrations of interleukin‐6 (IL‐6) and tumor necrosis factor α (TNFα) and to correlate changes in plasma IL‐6 levels with clinical symptoms during corticosteroid therapy. Methods. IL‐6 and TNFα concentrations were determined in plasma samples from patients with untreated PMR or GCA, and plasma IL‐6 levels were monitored in patients receiving long‐term therapy (14 months) with corticosteroids. To identify IL‐6–producing cells, the polymerase chain reaction was used to detect IL‐6 messenger RNA. In vitro production of IL‐6 and IL‐2 by peripheral blood mononuclear cells (PBMC) from treated and untreated patients was quantified using IL‐6– and IL‐2–specific bioassay systems. Results. IL‐6 concentrations were increased in PMR and GCA patients, whereas TNFα concentrations were similar to those in normal donors. Administration of corticosteroids rapidly reduced the levels of circulating IL‐6 but did not correct the underlying mechanism inducing the increased IL‐6 production. In individual patients, changes in plasma IL‐6 levels and clinical manifestations during prolonged therapy were closely correlated. Short‐term withdrawal of corticosteroids, even after several months of treatment, was followed by an immediate increase in plasma IL‐6 concentrations. To identify the cellular source of plasma IL‐6, PBMC from treated and untreated patients with PMR or GCA were analyzed for their ability to secrete IL‐6 and the T cell–specific cytokine IL‐2. Polyclonal T cell stimulation caused a rapid release of IL‐6, which was shown to be derived exclusively from CD14+ cells. Conclusion. Increased production of IL‐6, but not TNFα, is a characteristic finding in patients with PMR or GCA. Corticosteroids rapidly suppress IL‐6 production but do not correct the underlying mechanism inducing the increased IL‐6 production. The close correlation of plasma IL‐6 concentrations with clinical symptoms suggests a direct contribution of this cytokine to the disease manifestations and presents the possibility that monitoring IL‐6 levels would be useful in making decisions on adjustment of corticosteroid dosage in individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., & Coffman, R. L. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.001045 · Cited by 7,692
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Hunder, G. G., Bloch, D. A., Michel, B. A., Stevens, M. B., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., Lie, J. T., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330810 · Cited by 2,539
Self-citationAnti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Tracey, K. J., Fong, Y., Hesse, D. G., Manogue, K. R., Lee, A. T., Kuo, G. C., Lowry, S. F., & Cerami, A. (1987) · Nature · doi:10.1038/330662a0 · Cited by 2,448
Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
Gauldie, J., Richards, C., Harnish, D., Lansdorp, P., & Baumann, H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,479
CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
Arai, K.-I., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004031 · Cited by 1,318
Interleukin-1 and the Pathogenesis of the Acute-Phase Response
Epstein, F. H., & Dinarello, C. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411293112205 · Cited by 1,146
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., Sato, K., Shimi, M., Maid, R., Feldmann, M., et al. (1988) · European Journal of Immunology · doi:10.1002/eji.1830181122 · Cited by 784
Temporal Arteritis: A 25-Year Epidemiologic, Clinical, and Pathologic Study
HUSTON, K. A., HUNDER, G. G., LIE, J. T., KENNEDY, R. H., & ELVEBACK, L. R. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-2-162 · Cited by 547
Self-citation
Cited by
Trial of tocilizumab in giant-cell arteritis
Stone, J. H., Tuckwell, K., Dimonaco, S., Klearman, M., Aringer, M., Blockmans, D., Brouwer, E., Cid, M. C., Dasgupta, B., Rech, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613849 · Cited by 1,386
Medium- and Large-Vessel Vasculitis
Weyand, C. M., & Goronzy, J. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022694 · Cited by 788
Self-citationInflammation, Immunity, and Hypertensive End-Organ Damage
McMaster, W. G., Kirabo, A., Madhur, M. S., & Harrison, D. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.303697 · Cited by 708
Villiger, P. M., Adler, S., Kuchen, S., Wermelinger, F., Dan, D., Fiege, V., Bütikofer, L., Seitz, M., & Reichenbach, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00560-2 · Cited by 577
Giant-Cell Arteritis and Polymyalgia Rheumatica
Weyand, C. M., & Goronzy, J. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-6-200309160-00015 · Cited by 379
Self-citation
Metadata
- Authors
- Roche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., & Weyand, C. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1993-09
- Volume
- 36
- Issue
- 9
- Pages
- 1286-1294
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2093961109
- Cited by
- 347
- References
- 17
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. https://app.cochat.ai/papers/10.1002/art.1780360913
- The paper
- Roche, N. E., Fulbright, J. W., Wagner, A. D., Hunder, G. G., Goronzy, J. J., & Weyand, C. M. (1993). Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780360913
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.